开云app官网登录入口网页版-官方正版

#ratio#

19篇内容 | 590人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1793138, encodeId=29ab1e9313865, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=Neural Regeneration Research: dFCS可用于AD诊断、治疗和持续评估, objectType=article, longId=737384, objectId=5c65e3738414, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c65e3738414, replyNumber=0, likeNumber=90, createdTime=2022-12-03, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c65e3738414, moduleTitle=Neural Regeneration Research: dFCS可用于AD诊断、治疗和持续评估, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5c65e3738414)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793139, encodeId=75e31e9313973, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=ESMO 2022：替雷利珠单抗作为不可切除HCC一线治疗显示出非劣效于索拉非尼的OS获益（RATIONALE 301研究）, objectType=article, longId=739072, objectId=0c76e39072d5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0c76e39072d5, replyNumber=0, likeNumber=69, createdTime=2022-11-21, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0c76e39072d5, moduleTitle=ESMO 2022：替雷利珠单抗作为不可切除HCC一线治疗显示出非劣效于索拉非尼的OS获益（RATIONALE 301研究）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0c76e39072d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793137, encodeId=0de81e931371c, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=J Clin Oncol：RATIONALE-302研究证实Tislelizumab ( 替雷利珠单抗)二线治疗可改善晚期或转移性食管鳞状细胞癌（ESCC）患者的OS, objectType=article, longId=727477, objectId=0a19e27477f4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a19e27477f4, replyNumber=0, likeNumber=66, createdTime=2022-09-12, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a19e27477f4, moduleTitle=J Clin Oncol：RATIONALE-302研究证实Tislelizumab ( 替雷利珠单抗)二线治疗可改善晚期或转移性食管鳞状细胞癌（ESCC）患者的OS, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0a19e27477f4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793136, encodeId=aebf1e93136d0, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=AACR 2022：TMB不能成为好的免疫检查点抑制剂的biomarker (RATIONALE 304研究)?, objectType=article, longId=724034, objectId=348fe24034fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=348fe24034fa, replyNumber=0, likeNumber=73, createdTime=2023-01-07, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=348fe24034fa, moduleTitle=AACR 2022：TMB不能成为好的免疫检查点抑制剂的biomarker (RATIONALE 304研究)?, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=348fe24034fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793135, encodeId=afe81e931351a, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=AACR重磅之RATIONALE-304：肿瘤突变负荷（TMB）与替雷利珠单抗（TIS）+化疗（chemo）与单独化疗在晚期非鳞状非小细胞肺癌（nsq-NSCLC）一线治疗的临床结局研究, objectType=article, longId=723964, objectId=100be239645b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=100be239645b, replyNumber=0, likeNumber=100, createdTime=2023-01-21, rootId=0, userName=zhaojie88, userId=4c37265, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=100be239645b, moduleTitle=AACR重磅之RATIONALE-304：肿瘤突变负荷（TMB）与替雷利珠单抗（TIS）+化疗（chemo）与单独化疗在晚期非鳞状非小细胞肺癌（nsq-NSCLC）一线治疗的临床结局研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=100be239645b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793132, encodeId=b3651e931322f, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=Long non-coding RNA NORAD promotes cell proliferation and glycolysis in non-small cell lung cancer by acting as a sponge for miR-136-5p, objectType=article, longId=221116, objectId=2a872211164b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a872211164b, replyNumber=0, likeNumber=56, createdTime=2022-01-04, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a872211164b, moduleTitle=Long non-coding RNA NORAD promotes cell proliferation and glycolysis in non-small cell lung cancer by acting as a sponge for miR-136-5p, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=2a872211164b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793134, encodeId=10771e9313457, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=NEURAL REGENERATION RESEARCH：基于磁共振T1、T2加权的病变指数可识别2型糖尿病患者是否患有认知障碍, objectType=article, longId=293849, objectId=ef8229384996, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef8229384996, replyNumber=0, likeNumber=116, createdTime=2022-02-08, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef8229384996, moduleTitle=NEURAL REGENERATION RESEARCH：基于磁共振T1、T2加权的病变指数可识别2型糖尿病患者是否患有认知障碍, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ef8229384996)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793131, encodeId=e24c1e93131f9, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=Effect of oxaliplatin combined with polyenephosphatidylcholine on the proliferation of human gastric cancer SGC_901 cells, objectType=article, longId=221035, objectId=260322103535, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=260322103535, replyNumber=0, likeNumber=61, createdTime=2022-01-21, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=260322103535, moduleTitle=Effect of oxaliplatin combined with polyenephosphatidylcholine on the proliferation of human gastric cancer SGC_901 cells, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=260322103535)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793129, encodeId=3f311e93129ff, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=Neural Regeneration Research：脑胰岛素抵抗是唐氏综合征阿尔茨海默病发展的早期危险因素, objectType=article, longId=214895, objectId=d59c21489526, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d59c21489526, replyNumber=0, likeNumber=67, createdTime=2021-08-25, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d59c21489526, moduleTitle=Neural Regeneration Research：脑胰岛素抵抗是唐氏综合征阿尔茨海默病发展的早期危险因素, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d59c21489526)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793130, encodeId=02ec1e9313016, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1, objectType=article, longId=220880, objectId=1f00220880cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1f00220880cb, replyNumber=0, likeNumber=53, createdTime=2022-11-07, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1f00220880cb, moduleTitle=miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1f00220880cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793133, encodeId=442b1e931337d, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=SOX10 Knockdown Lnhibits Melanoma Cell Proliferation via Notch Signaling Pathway, objectType=article, longId=221348, objectId=5af122134869, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5af122134869, replyNumber=0, likeNumber=51, createdTime=2022-07-11, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5af122134869, moduleTitle=SOX10 Knockdown Lnhibits Melanoma Cell Proliferation via Notch Signaling Pathway, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5af122134869)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793128, encodeId=25be1e9312846, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=J Thorac Oncol: 替雷利珠单抗（Tislelizumab）联合化疗一线治疗局部进展或转移性非鳞状非小细胞肺癌（nsq-NSCLC）的疗效和安全性(RATIONALE 304): 3期临床研究, objectType=article, longId=213120, objectId=686b21312019, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=686b21312019, replyNumber=0, likeNumber=73, createdTime=2022-04-14, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=686b21312019, moduleTitle=J Thorac Oncol: 替雷利珠单抗（Tislelizumab）联合化疗一线治疗局部进展或转移性非鳞状非小细胞肺癌（nsq-NSCLC）的疗效和安全性(RATIONALE 304): 3期临床研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=686b21312019)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793127, encodeId=0a121e93127d1, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=International Diabetes Federation:国际糖尿病联盟发布新版糖尿病地图：中国1.14亿，仍是全球冠军，女性教育是防治关键, objectType=article, longId=121688, objectId=d6c6121688fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d6c6121688fd, replyNumber=0, likeNumber=59, createdTime=2018-02-11, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d6c6121688fd, moduleTitle=International Diabetes Federation:国际糖尿病联盟发布新版糖尿病地图：中国1.14亿，仍是全球冠军，女性教育是防治关键, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d6c6121688fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793125, encodeId=f2251e931253c, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=Mol Neurodegeneration:一种新型顺向跨突触神经环路示踪工具, objectType=article, longId=100410, objectId=588c1004105f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=588c1004105f, replyNumber=0, likeNumber=67, createdTime=2018-04-21, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=588c1004105f, moduleTitle=Mol Neurodegeneration:一种新型顺向跨突触神经环路示踪工具, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=588c1004105f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793126, encodeId=e8421e931265a, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=Ascensia Diabetes Care与Insulet Corporation达成战略性联盟, objectType=article, longId=101601, objectId=32ab10160135, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=32ab10160135, replyNumber=0, likeNumber=59, createdTime=2017-07-29, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=32ab10160135, moduleTitle=Ascensia Diabetes Care与Insulet Corporation达成战略性联盟, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=32ab10160135)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793124, encodeId=56371e9312414, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=Lancet子刊：每周1次艾塞那肽与甘精胰岛素治疗2型糖尿病的对比研究（DURATION-3研究), objectType=article, longId=41434, objectId=3dd94143451, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3dd94143451, replyNumber=0, likeNumber=75, createdTime=2014-11-04, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3dd94143451, moduleTitle=Lancet子刊：每周1次艾塞那肽与甘精胰岛素治疗2型糖尿病的对比研究（DURATION-3研究), moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3dd94143451)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793122, encodeId=8a251e93122d1, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=Respiration：HSP27成慢性阻塞性肺病（COPD）检测新标志物, objectType=article, longId=5614, objectId=18fc5614a4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18fc5614a4, replyNumber=0, likeNumber=70, createdTime=2012-06-02, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18fc5614a4, moduleTitle=Respiration：HSP27成慢性阻塞性肺病（COPD）检测新标志物, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=18fc5614a4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793123, encodeId=aea51e9312315, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=Inspiration公司向FDA提交IB1001(重组凝血因子IX)生物制品许可申请, objectType=article, longId=5767, objectId=e6075e6789, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e6075e6789, replyNumber=0, likeNumber=75, createdTime=2012-07-10, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e6075e6789, moduleTitle=Inspiration公司向FDA提交IB1001(重组凝血因子IX)生物制品许可申请, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e6075e6789)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1793121, encodeId=feec1e93121b1, content=<a href='/topic/show?id=d27515154f8' target=_blank style='color:#2F92EE;'>#ratio#</a>, objectTitle=operation手术翻译大全, objectType=article, longId=359, objectId=84093595a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=84093595a, replyNumber=0, likeNumber=60, createdTime=2010-09-23, rootId=0, userName=yuhaisheng_ibp_32061711, userId=bb182500058, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=84093595a, moduleTitle=operation手术翻译大全, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=84093595a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

ratio

2020-05-29

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

Neural Regeneration Research: dFCS可用于AD诊断、治疗和持续评估

2022-12-03

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

ESMO 2022：替雷利珠单抗作为不可切除HCC一线治疗显示出非劣效于索拉非尼的OS获益（RATIONALE 301研究）

2022-11-21

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

J Clin Oncol：RATIONALE-302研究证实Tislelizumab ( 替雷利珠单抗)二线治疗可改善晚期或转移性食管鳞状细胞癌（ESCC）患者的OS

2022-09-12

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

AACR 2022：TMB不能成为好的免疫检查点抑制剂的biomarker (RATIONALE 304研究)?

2023-01-07

zhaojie88 (审核中...)

前往app查看评论内容

#ratio#

AACR重磅之RATIONALE-304：肿瘤突变负荷（TMB）与替雷利珠单抗（TIS）+化疗（chemo）与单独化疗在晚期非鳞状非小细胞肺癌（nsq-NSCLC）一线治疗的临床结局研究

2023-01-21

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

Long non-coding RNA NORAD promotes cell proliferation and glycolysis in non-small cell lung cancer by acting as a sponge for miR-136-5p

2022-01-04

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

NEURAL REGENERATION RESEARCH：基于磁共振T1、T2加权的病变指数可识别2型糖尿病患者是否患有认知障碍

2022-02-08

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

Effect of oxaliplatin combined with polyenephosphatidylcholine on the proliferation of human gastric cancer SGC_901 cells

2022-01-21

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

Neural Regeneration Research：脑胰岛素抵抗是唐氏综合征阿尔茨海默病发展的早期危险因素

2021-08-25

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

miRNA-34a decreases ovarian cancer cell proliferation and chemoresistance by targeting HDAC1

2022-11-07

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

SOX10 Knockdown Lnhibits Melanoma Cell Proliferation via Notch Signaling Pathway

2022-07-11

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

J Thorac Oncol: 替雷利珠单抗（Tislelizumab）联合化疗一线治疗局部进展或转移性非鳞状非小细胞肺癌（nsq-NSCLC）的疗效和安全性(RATIONALE 304): 3期临床研究

2022-04-14

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

International Diabetes Federation:国际糖尿病联盟发布新版糖尿病地图：中国1.14亿，仍是全球冠军，女性教育是防治关键

2018-02-11

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

Mol Neurodegeneration:一种新型顺向跨突触神经环路示踪工具

2018-04-21

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

Ascensia Diabetes Care与Insulet Corporation达成战略性联盟

2017-07-29

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

Lancet子刊：每周1次艾塞那肽与甘精胰岛素治疗2型糖尿病的对比研究（DURATION-3研究)

2014-11-04

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

Respiration：HSP27成慢性阻塞性肺病（COPD）检测新标志物

2012-06-02

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

Inspiration公司向FDA提交IB1001(重组凝血因子IX)生物制品许可申请

2012-07-10

yuhaisheng_ibp_32061711 (审核中...)

前往app查看评论内容

#ratio#

operation手术翻译大全

2010-09-23

科室
- - 订阅+
  - 更多科室
工具
服务